Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
May 07, 2019
Double-Bottom Pattern for biotech ETF should help move it higher

Double-Bottom Pattern for biotech ETF should help move it higher

Biotech and pharmaceutical stocks went through a rather bad selloff in the middle of April. The SPDR S&P Biotech ETF (NYSE: XBI)fell just shy of 10% from April 5 through April 22 before it bounced a little. The Healthcare Select Sector SPDR (NYSE: XLV) fell 6.5% during that same stretch. The S&P 500 was up 0.5% during that same time period, meaning healthcare and biotech stocks underperformed the overall market rather dramatically during that stretch.

The XBI rallied for just over a week before dipping a second time and once again it moved down to the $82.50 area before bouncing back in the last few days. This looks like a double-bottom pattern to me and that is a possible bullish sign for the fund. 

The Tickeron AI Trend Prediction tool generated a bullish signal for the XBI on May 3. That signal showed a confidence level of 88% and it calls for a move of at least 4% over the next month. Previous predictions on the XBI have been successful 88% of the time. 

The selling in the healthcare and biotech industries was somewhat odd in that there didn’t seem to be a story that created all of the selling. There were some talks of Democrats in Congress pushing for Medicare for all, but even if that had a chance to pass the Republican-controlled Senate, it would take years to implement. 

Another possibility could have been some profit taking ahead of earnings reports, but the argument didn’t seem all that valid either. It could have been that some selling in a few stocks created sell triggers on other stocks and the program trading took over and became a self-fulfilling prophecy—program selling created more selling and caused the decline. 

Regardless of the reason behind the selloff, it appears to be a thing of the past at this time. 


Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


AI Patterns 1
Interact to see
Advertisement
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.